Dr. Tsu-Tsair Chi, N.M.D, PhD was the head of oncology
research for 2 major US drug companies. Having medical
training in China and having earned a
PhD in biochemistry from the Waksman Institute of Microbiology
at Rutgers State University,
Dr. Chi saw, that according to the statistics for the
chemotherapy he was helping to create that the outcomes
for cancer patients using the Chinese Herbal Medicine
he had learned were better than the results of chemotherapy
on US patients. Following his conscience, he left the
pharmaceutical firms and established his own company
to bring to the US chinese herbal formulas that were
useful against cancer and the things that create it.
Over 99% of all cancers are driven
by estrogen. In conventional medicine, drug related
estrogen control (ie: Tamoxifen) is extremely toxic
and has many negative side effects. Drugs like Tamoxifen
and other pharmaceutical estrogen blockers
act as E blockers in some tissue (like the breasts)
while acting as estrogen in others (like the womb)
which is why Tamoxifen users have such a high incidence
of Uterine cancer.
The first thing
Dr. Chi had to develop was a way of controlling both
the formation and utilization of estrogen that had
no side effects and no toxicity. The resulting product
is: Myomin.
Since estrogen control is essential, not
just for fighting cancer, but for fibroids, endometriosis,
fibrocystic breast disease, and ovarian cysts in
women and overcoming andropause in men, the Myomin
is applicable to anyone needing to gain control
over their estrogen dominance.
Myomin acts
as both an estrogen blocker and aromatase inhibitor
(keeps the body from making estrogen) without side
effects or heavy toxicity and has
been reported to reduce the size and symptoms of
myoma. It may also boost the
formation of interferon interlukin-2 and tumor necrosis
factor.
